Cargando…
Drug Development to Protozoan Diseases
The diseases caused by protozoan parasite are responsible for considerable mortality and morbidity, affecting more than 500 million of people in the world. The epidemiological control of protozoan is unsatisfactory due to difficulties of vector and reservoir control; while the progress in the develo...
Autores principales: | Monzote, Lianet, Siddiq, Afshan |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Bentham Open
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3103878/ https://www.ncbi.nlm.nih.gov/pubmed/21629506 http://dx.doi.org/10.2174/1874104501105010001 |
Ejemplares similares
-
HIV Protease Inhibitors: Effect on the Opportunistic Protozoan Parasites
por: Alfonso, Yenisey, et al.
Publicado: (2011) -
Bioactive Essential Oils from Cuban Plants: An Inspiration to Drug Development
por: Monzote, Lianet, et al.
Publicado: (2021) -
Tropical Protozoan Diseases: Natural Product Drug Discovery and Development
por: Muschietti, Liliana, et al.
Publicado: (2013) -
Antileishmanial Potential of Tropical Rainforest Plant Extracts
por: Monzote, Lianet, et al.
Publicado: (2014) -
Thiadiazine Derivatives as Antiprotozoal New Drugs
por: Bermello, Julieta Coro, et al.
Publicado: (2011)